Retatrutide, from Soma Pharmaceuticals , represents a significant development in weight regulation. This innovative medication combines incretin signaling properties with another pathway stimulation , indicating impressive efficacy in trial studies for weight loss . Experts believe the drug may offer a new option for patients facing obesity conditi